Shares of Hologic Inc. HOLX rallied 1.88% to $57.56 Thursday, on what proved to be an all-around mixed trading session for ...

Hologic Inc. closed 31.68% below its 52-week high of $84.67, which the company reached on August 9th.

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing ...

Mizuho lowered the firm’s price target on Hologic (HOLX) to $75 from $83 and keeps an Outperform rating on the shares as part of a Q1 preview ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

BofA lowered the firm’s price target on Hologic (HOLX) to $70 from $86 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report) has earned a consensus recommendation of “Hold” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Eleven ...

Currently, McMillan serves as CFO at Solventum, the 3M Health Care spinoff. He officially became Solventum’s CFO after its ...

Hologic (HOLX) ended the recent trading session at $58.84, demonstrating a +1.71% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.79%.

MARLBOROUGH, Mass. - Hologic, Inc. (NASDAQ:HOLX), a medical technology company with a market capitalization of $13.7 billion, announced today that Wayde McMillan has been elected to its Board of ...

Hologic, Inc. (Nasdaq: HOLX) announced today that Wayde McMillan has been elected to the Company’s Board of Directors, effective April 4, 2025. Mr. McMillan was also appointed to the Audit and ...